A retrospective study following patients profile and effectiveness of chronic hepatitis C treatment with glecaprevir/pibrentasvir (GP) in real-world settings
Latest Information Update: 17 Feb 2020
At a glance
- Drugs Glecaprevir/pibrentasvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
Most Recent Events
- 17 Feb 2020 New trial record